Additional file 6 of A multidimensional assessment of adverse events associated with paliperidone palmitate: a real-world pharmacovigilance study using the FAERS and JADER databases

Supplementary Material 6. Table S4: Comprehensive gender-differentiated risk signal analysis results of paliperidone palmitate-associated adverse drug events (ADEs). the ROR algorithm's is not strictly a pharmacovigilance analysis method. Here, a means the number of reports of target ADE in female; b, number of reports of other ADEs in female; c, number of reports of target ADE in male; d, number of reports of other ADEs in male. Therefore, the ROR here is not a strictly defined ROR in pharmacoepidemiological perspective; we just use this algorithm for signal value calculation of gender-based signal strength differences.